The Kuwaiti government is set to pay $1.4 million for 5.4 million doses of a liquid drug intended to safeguard people from thyroid cancer that can be caused by exposure to radiation, United Press International reported Friday (see GSN, Jan. 29, 2008).
"This sale is the first large-scale order of ThyroShield from a foreign government," according to a statement from Troy Jones, president of U.S.-based supplier Nukepills.com. "We are currently working on additional potassium iodide orders from other countries in the Middle East, Europe and Asia. We hope the new administration follows Kuwait's lead and reinstitutes the potassium iodide distribution plan to protect its citizens" (United Press International, Jan. 23).